Phase 2 Sleep Disorders Trial, Recruiting NCT06968000 Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz Condition: Sleep Disorders
Back to Sleep Disorders

Phase 2 Sleep Disorders Trial, Recruiting

NCT06968000
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older, regardless of whether you are male or female
  • You are scheduled for a planned (non-emergency) general surgery, ideally involving the liver or bile duct area
  • You are expected to stay in the hospital for at least 4 days after your surgery in a specific unit (Unit 69 at HUFJD)
  • You are able to read and sign a consent form agreeing to take part
  • Your doctors consider you to be at medium or high risk of having certain problems with how your cells produce energy or handle stress (confirm with trial site)

Who may not be able to join:

  • You have had any surgery in the last 6 months, whether it was a day procedure or required a hospital stay
  • You have been diagnosed with a mental health or neurological condition, including epilepsy
  • You currently have an active, progressing cancer or a long-term inflammatory condition
  • You have memory or thinking difficulties that would make it hard to follow the study's instructions
  • Your body mass index (BMI) — a measure of weight relative to height — is 30 or above (considered obese)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Hormetic clinical response associated with EOX exposure during the first 96 hours post-surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov